Management of acquired uterine arteriovenous malformations following early pregnancy complications by Cheung, VYT & Ko, KYJ
Title Management of acquired uterine arteriovenous malformationsfollowing early pregnancy complications
Author(s) Ko, KYJ; Cheung, VYT




Journal of Paediatrics, Obstetrics and Gynaecology. Copyright ©
MIMS (Hong Kong) Limited.; This work is licensed under a
Creative Commons Attribution-NonCommercial-NoDerivatives
4.0 International License.
MIMS JPOG JUL/AUG 2017CONTINUING MEDICAL EDUCATION 169
Management of Acquired 
Uterine Arteriovenous 
Malformations Following Early 
Pregnancy Complications
Jennifer K.Y. Ko, MBBS, MRCOG, FHKCOG, Cert RCOG (Reprod Med), FHKAM; Vincent Y.T. Cheung, MBBS, FRCOG, FRCSC
INTRODUCTION
Uterine arteriovenous malformation (AVM) 
is an abnormal connection between arter-
ies and veins within the uterus. Although 
AVM can be congenital or acquired, this 
article focuses on the diagnosis and man-
agement of acquired AVMs identified fol-
lowing early pregnancy complications. 
AVMs may develop as a result of damage 
to the uterine tissue following spontane-
ous miscarriage, pregnancy termination, 
dilatation and curettage, caesarean scar 
pregnancy, or gestational trophoblastic 
disease.1 The incorporation of necrotic 
villi in the venous sinuses of scar tissue is 
thought to cause acquired AVM.2
DIAGNOSIS
The most common presenting symp-
tom of uterine AVM is abnormal uterine 
bleeding. The bleeding pattern is typically 
intermittent and/or torrential, and unre-
sponsive to medical management,3 with 
approximately 30% of cases requiring 
blood transfusion.4
Angiography is still the gold 
standard for diagnosing AVM,4 but its 
invasive nature limits its use hence, it 
is now often reserved for patients who 
require intervention at the same setting 
(Figure 1). Currently, ultrasonography 
is the primary tool for the diagnosis of 
uterine AVM.5 In recent years, the wide-
spread use of ultrasonography during 
follow-up after early pregnancy com-
plications has led to an increasing in-
cidence of vascular lesions resembling 
AVM in asymptomatic women. Some 
1 POINT
Figure 1. Abnormal vessels with hypertrophied complex feeding artery and early venous 
drainage on angiography suggestive of uterine AVM
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authors refer these lesions, which can 
be indistinguishable from retained 




tics of EMV/AVM on two-dimensional 
grayscale ultrasonography are non-
specific, which appears as irregular, 
hypoechoic tubular structures within 
the myometrium, and the diagnosis 
can be missed if not clinically aware 
(Figure 2).1 The complex network of 
EMV/AVM may be enhanced by us-
ing colour Doppler ultrasonography 
which shows a mosaic pattern of multi-
directional vessels with high-velocity 
and low-impedance flow (Figure 3).1-2 
The use of three-dimensional colour 
Doppler ultrasonography can clearly 
demonstrate the configuration as well 
as feeding and draining vessel of the 
EMV/AVM.1
Saline infusion ultrasonography, 
magnetic resonance imaging (MRI), 
contrast-enhanced computed tomog-
raphy (CT), and hysteroscopy have 
also been used for the diagnosis of 
EMV/AVM and to further characterise 
the lesion.6-9 On CT and MRI, charac-
teristic appearances of EMV/AVM are 
serpiginous flow-related signal voids 
within the lesion.7 Both CT and MRI 
evaluate the involvement of surround-
ing visceral structures and are useful 
when the body habitus limits ultra-
sonographic images. However, MRI 
provides better tissue contrast com-
pared with CT and does not involve 
radiation exposure.10 
It is important to accurately diag-
nose gestational trophoblastic disease 
or retained products of gestation in 
abnormal vaginal bleeding post preg-
nancy, as uterine curettage in a wom-
an with undiagnosed uterine EMV/AVM 
can provoke life-threatening bleeding. 
Unlike gestational trophoblastic disease 
or retained products of gestation, beta- 
human chorionic gonadotropin (β-hCG) 
is usually negative in AVM, and this 
might be beneficial in diagnosis. 
MANAGEMENT
Timmerman, et al, suggested that wom-
en with uterine AVMs should be clas-
sified into three groups: (1) those with 
true AVMs with heavy, life-threatening 
uterine bleeding in nearly all cases, 
and colour Doppler evidence showing 
typical signs of vascular malformation 
including areas of strong hypervas-
cularity and turbulence confirmed by 
angiography; (2) those with profound 
uterine bleeding and characteristic 
appearance on Doppler ultrasound 
but not angiographically confirmed; 
and (3) those with minimal symptoms 
and ultrasound features of vascular 
malformation.11
The most important determinant in 
EMV/AVM management is the woman’s 
clinical status, taking into consideration 
the woman’s age and desire for further 
fertility. Women with life-threatening and 
profound uterine bleeding (groups 1 and 
2) need a timely and definitive treatment 
such as hysterectomy, which should be 
considered for those with haemodynamic 
instability and life-threatening bleeding. 
However, this would result in permanent 
loss of fertility. While awaiting definitive 
treatment, acute blood loss may be suc-
cessfully controlled by an intrauterine 
Foley catheter4 and should be accompa-
CT and MRI evaluate the involvement of surrounding visceral structures and are useful 
when the body habitus limits ultrasonographic images.
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nied by aggressive resuscitation and re-
placement of blood products as needed.
Most women diagnosed with EMV/
AVM are in the reproductive age group 
who still desire fertility. Therefore, treat-
ment should be aimed at preserving fertil-
ity whenever possible. Women with EMV/
AVM requiring fertility-sparing manage-
ment should be referred early to a tertiary 
centre with the appropriate expertise. 
High success rates have been reported 
for uterine artery embolization, which is 
the most common treatment modality for 
EMV/AVM.7,12-15 Various embolic agents 
such as gelfoam, polyvinyl alcohol par-
ticles, tissue glue, and coils have been 
used with no statistically significant dif-
ference in clinical outcomes reported.16 
The use of unilateral or bilateral emboli-
zation approach should be based on the 
arterial supply as determined by angiog-
raphy, clinical scenario, and preference 
of the radiologist.10 Although postembo-
lization syndrome with pelvic pain and 
low-grade fever can occur, this often sub-
sides with conservative management.15
Laparoscopic treatment using bi-
polar coagulation of uterine vessels or 
myometrial resection has been reported 
in selected cases.17-18 In a recent retro-
spective study, 11 women with uterine 
EMV/AVM were successfully treated us-
ing surgical hysteroscopy equipped with 
an electrosurgical loop, which offers the 
advantage of a short hospital stay and 
has no reported complications.19
A new form of minimally invasive 
treatment makes use of a human fi-
brin sealant applied selectively to the 
feeding vessel of the AVM under sono-
graphic guidance. The sealant is a 
biological substance derived from hu-
man donor plasma, producing a high-
ly concentrated solution of fibrinogen 
and other cryoglobulins, mimicking the 
final stages of the body’s natural clot-
ting cascade. In a previous study, 14 
women who had postpartum haemor-
rhage caused by AVM were successful-
ly treated; however, 3 women required 
a repeat procedure after 4–7 days.20
Women with minimal or no abnor-
mal bleeding (group 3) constitute the 
majority of those diagnosed with EMV/
AVM on ultrasonography during fol-
low-up of pregnancy complications. 
However, the natural course, the likeli-
Figure 2. EMV/AVM on two-dimensional grayscale ultrasonography are nonspecific and appears as irregular, hypoechoic tubular structures 
within the myometrium.
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hood of bleeding, and the need for in-
tervention in this group of women are 
not clear. In the study of Timmerman, et 
al, conservative management was pos-
sible in more than two-thirds of patients 
presenting with uterine AVM diagnosed 
by colour Doppler ultrasonography.11 In 
a retrospective review of 22 EMV/AVM 
cases from our centre, while almost 
10% of women with EMV/AVM had un-
predictable uterine bleeding requiring 
angiographic intervention, this only oc-
curred in women with ongoing abnor-
mal bleeding after the pregnancy event. 
In women who were asymptomatic at 
the time of diagnosis, the EMV/AVM 
resolved spontaneously without unpre-
dictable bleeding.21
Peak systolic velocity (PSV) has 
been suggested to be useful in distin-
guishing between patients with high- 
and low-risk bleeding.1,11,22 Despite sig-
nificant overlap of PSV values between 
the two groups, patients who required 
uterine artery embolization had a higher 
mean PSV compared with those who did 
not require embolization. Timmerman, 
et al, proposed that a PSV of less than 
0.39 m/s should be considered “safe” 
for conservative management, particu-
larly in asymptomatic patients, while 
those greater than 0.83 m/s should be 
re-evaluated at regular intervals.11 
In a prospective study of 75 wom-
en with vaginal bleeding from pregnan-
cy-related EMV/AVM, the mean haemo-
globin of patients who had conservative 
management was found to be signifi-
cantly higher than those who had thera-
peutic management.22 In that study, the 
diagnostic predictive value of spectral 
Doppler and haemoglobin level in cor-
rectly classifying patients into conserv-
ative and therapeutic management was 
up to 85.3%.22
In our experience, ultrasonographic 
resolution of the EVM/AVM can take up 
to 12 months.21 Even though majority 
of patients can be reassured, those on 
conservative management should be 
advised to seek medical attention if ab-
normal vaginal bleeding occurs. Patients 
should be advised against travelling 
to areas without access to appropriate 
treatment without ultrasound confirma-
tion that the lesion has resolved.
There have been reports of suc-
cessful pregnancies after AVM, including 
those who have undergone uterine artery 
embolization,3,19 which is a selective pro-
cess that should not affect the menstrual 
cycle and fertility in the majority of cases. 
Adequate collateral blood supply can 
Figure 3. Typical colour Doppler image of EMV/AVM showing increase in vascular flow at the fundus and posterior wall on transvaginal 
ultrasonography.
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develop after the procedure to maintain 
uterine perfusion for pregnancy. In a retro-
spective case series and literature review 
conducted at Canberra Hospital, 28 wom-
en achieved 36 pregnancies and 32 live 
births after diagnosis and/or treatment of 
uterine EMV/AVM.23 In that study, none 
of the women had severe intrauterine 
growth restriction or abnormal invasion 
of the placental bed.19 However, the num-
bers are small and continued monitoring 
of the pregnancy outcome after manage-
ment of EMV/AVM should be done.
CONCLUSION
Pregnancy is an important cause of ac-
quired EMV/AVM. Diagnosis is most of-
ten by colour Doppler ultrasonography. 
Patients should be managed based on 
their clinical status, taking into account 
objective measurements such as Doppler 
indices and haemoglobin levels. Most 
asymptomatic women can be reassured 
that EMV/AVM will resolve without signif-
icant sequelae. Uterine artery emboliza-
tion is the most common fertility-sparing 
treatment modality for those with signifi-
cant bleeding, with high success rates.
About the authors
Dr Jennifer K.Y. Ko is an Associate Consultant in the 
Department of Obstetrics and Gynaecology, Queen Mary 
Hospital, The University of Hong Kong, Hong Kong.
 
Dr Vincent Y.T. Cheung is a Consultant Gynaecologist in the 
Department of Obstetrics and Gynaecology, Queen Mary 
Hospital, The University of Hong Kong, Hong Kong.
REFERENCES
1. Timor-Tritsch, I.E., Haynes, M.C., Mon-
teagudo, A., Khatib, N. & Kovacs, S. (2016) 
Ultrasound diagnosis and management of 
acquired uterine enhanced myometrial vas-
cularity/arteriovenous malformations. Am J 
Obstet Gynecol 2016;214:731.e1–731.e10.
2. Timmerman, D., Van den Bosch, T., Peer-
aer, K., Debrouwere, E., Van Schoubroeck, 
D., Stockx, L. & Spitz, B. (2000) Vascular 
malformations in the uterus: ultrasono-
graphic diagnosis and conservative man-
agement. Eur J Obstet Gynecol Reprod Biol 
2000;92:171–178.
3. Grivell, R.M., Reid, K.M. & Mellor, A. 
(2005) Uterine arteriovenous malformations: 
a review of the current literature. Obstet Gy-
necol Surv 2005;60:761–767.
4. Manolitsas, T., Hurley, V. & Gilford, E. 
(1994) Uterine arteriovenous malformation--a 
rare cause of uterine haemorrhage. Aust N Z 
J Obstet Gynaecol 1994;34:197–199.
5. Cura, M., Martinez, N., Cura, A., Dalsa-
so, T.J. & Elmerhi, F. (2009) Arteriovenous 
malformations of the uterus. Acta Radiol 
2009;50:823–829.
6. Fakhri, A., Fishman, E.K., Mitchell, S.E., 
Siegelman, S.S. & White, R.I. (1987) The role 
of CT in the management of pelvic arterio-
venous malformations. Cardiovasc Intervent 
Radiol 1987;10:96–99.
7. Hugues, C., Le Bras, Y., Coatleven, F., 
Brun, J.L., Trillaud, H., Grenier, N. & Corne-
lis, F. (2015) Vascular uterine abnormalities: 
Comparison of imaging findings and clinical 
outcomes. Eur J Radiol 2015;84:2485–2491.
8. Calzolari, S., Cozzolino, M. & Castellacci, 
E. (2016) Uterine Arteriovenous Malforma-
tion: Hysteroscopic Identification Is Possible. 
J Minim Invasive Gynecol 2016;23:293–294.
9. Corticelli, A., Podesta, M., Pedretti, 
L., Papadia, A., Francescangeli, E. & Va-
lenzano, M. (2005) Uterine arteriovenous 
malformation: a case report diagnosed by 
sonohysterography. Clin Exp Obstet Gynecol 
2005;32:132–134.
10. Yoon, D.J., Jones, M., Taani, J.A., Buhim-
schi, C. & Dowell, J.D. (2016) A Systematic 
Review of Acquired Uterine Arteriovenous 
Malformations: Pathophysiology, Diagno-
sis, and Transcatheter Treatment. AJP Rep 
2016;6:e6–e14.
11. Timmerman, D., Wauters, J., Van Calen-
bergh, S., Van Schoubroeck, D., Maleux, G., 
Van Den Bosch, T. & Spitz, B. (2003) Color 
Doppler imaging is a valuable tool for the 
diagnosis and management of uterine vas-
cular malformations. Ultrasound Obstet Gy-
necol 2003;21:570–577.
12. Yang, J.J., Xiang, Y., Wan, X.R. & Yang, 
X.Y. (2005) Diagnosis and management of 
uterine arteriovenous fistulas with massive 
vaginal bleeding. Int J Gynaecol Obstet 
2005;89:114–119.
13. Kim, T.H. & Lee, H.H. (2010) Presenting 
features of women with uterine arteriovenous 
malformations. Fertil Steril 2010;94:2330.e7–
e10
14. Peitsidis, P., Manolakos, E., Tsekoura, V., 
Kreienberg, R. & Schwentner, L. (2011) Uter-
ine arteriovenous malformations induced af-
ter diagnostic curettage: a systematic review. 
Arch Gynecol Obstet 2011;284:1137–1151.
15. Wang, Z., Chen, J., Shi, H., Zhou, K., 
Sun, H., Li, X., Pan, J., Zhang, X., Liu, W., 
Yang, N. & Jin, Z. (2012) Efficacy and safe-
ty of embolization in iatrogenic traumatic 
uterine vascular malformations. Clin Radiol 
2012;67:541–545.
16. Ghai, S., Rajan, D.K., Asch, M.R., Mu-
radali, D., Simons, M.E. & TerBrugge, K.G. 
(2003) Efficacy of embolization in traumatic 
uterine vascular malformations. J Vasc Interv 
Radiol 2003;14:1401–1408.
17. Chen, S.Q., Jiang, H.Y., Li, J.B., Fan, L., 
Liu, M.J. & Yao, S.Z. (2013) Treatment of 
uterine arteriovenous malformation by myo-
metrial lesion resection combined with artery 
occlusion under laparoscopy: a case report 
and literature review. Eur J Obstet Gynecol 
Reprod Biol 2013;169:172–176.
18. Wu, Y.C., Liu, W.M., Yuan, C.C. & Ng, H.T. 
(2001) Successful treatment of symptomatic 
arteriovenous malformation of the uterus us-
ing laparoscopic bipolar coagulation of uter-
ine vessels. Fertil Steril 2001;76:1270–1271.
19. Calzolari, S., Cozzolino, M., Castellacci, 
E., Dubini, V., Farruggia, A. & Sisti, G. (2017) 
Hysteroscopic Management of Uterine Ar-
teriovenous Malformation. JSLS 2017;21. 
pii:e2016.00109.
20. Bandura, P., Rawnaq, T., Holzknecht, A., 
Cetin, E., Reemts, P., Zoi, P. & Schwarzler, P. 
(2015) Management of Intrauterine Arterio-
venous Malformation (AVM) in 14 Patients by 
Sonographically Guided Tisseel Application. 
Ultraschall Med 2015.
21. Ko, J.K., Cheung, V.Y. & Khongsni, P. 
(2016) Management and outcome of sono-
graphically diagnosed uterine enhanced 
myometrial vascularity / arteriovenous mal-
formations following early pregnancy events: 
a single center experience. Med Ultrason 
2016;18:403–404.
22. Lee, T.Y., Kim, S.H., Lee, H.J., Kim, M.J., 
Lee, S.K., Kim, Y.H. & Cho, S.H. (2014) Ul-
trasonographic indications for conserva-
tive treatment in pregnancy-related uterine 
arteriovenous malformations. Acta Radiol 
2014;55:1145–1152.
23. Eling, R., Kent, A. & Robertson, M. 
(2012) Pregnancy after uterine arterio-
venous malformation-case series and lit-
erature review. Australas J Ultrasound Med 
2012;15:87–96.
Women with EMV/AVM requiring fertility-sparing management should be referred early to  
a tertiary centre with the appropriate expertise.
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CME ARTICLE 
Management of Acquired Uterine 
Arteriovenous Malformations  
Following Early Pregnancy 
Complications
Answer True or False to the questions below.
This continuing medical education service is brought to you by MIMS. Read the article 
‘Management of Acquired Uterine Arteriovenous Malformations Following Early Pregnancy 
Complications’ and answer the following questions. This MIMS JPOG article has been 
accredited for CME by the Hong Kong College of Obstetricians and Gynaecologists.
1. Acquired uterine EMV/AVM can occur following early pregnancy complications.
2. The gold standard for diagnosis of uterine EMV/AVM is hysteroscopy.
3.  Angiography should be performed to confirm the diagnosis in patients with 
incidental finding of suspected uterine EMV/AVM on ultrasonography after an 
early pregnancy complication.
4.  Conservative management should be adopted for a patient with suspected uterine 
EMV/AVM presenting with heavy vaginal bleeding and anaemia to preserve fertility.
5.  Doppler indices can be used to triage asymptomatic patients with uterine EMV/
AVM for conservative management or treatment with uterine artery embolization.
6.  Uterine curettage should be performed in patients with suspected uterine EMV/
AVM to rule out retained products of gestation.
7. Uterine artery embolization is an effective treatment for symptomatic EMV/AVM.
8.  A Foley catheter can be used to provide intrauterine tamponade effect to arrest 
bleeding from uterine EMV/AVM while arranging more definitive treatment such as 
uterine artery embolization or hysterectomy.
9.  Most patients with asymptomatic EMV/AVM had a resolution of the condition with 
conservative management.
10.  Patients should be advised against travelling to remote areas until ultrasonographic 
resolution of the EMV/AVM.
True False
Name in BLOCK CAPITALS: ______________________________
Signature: ______________________________________________
Date: ___________________________________________________
Please mail your completed answer sheet back to:
The Secretariat
Hong Kong College of Obstetricians & Gynaecologists
Room 805, Hong Kong Academy of Medicine Jockey Club Building
99 Wong Chuk Hang Road, Aberdeen, Hong Kong
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